SCHEMBL16295878

SCHEMBL16295878

NC1CCN(O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16343715 1.00 — —
SCHEMBL14540865 0.83 — —
SCHEMBL5440944 0.81 — —
Hydrochloric Acid SCHEMBL28803262 0.79 HRH4 (0.30) —
Tert-Butyl Formate SCHEMBL28811787 0.75 TDP1 (0.43) —
SCHEMBL14960418 0.73 — —
SCHEMBL8009629 0.69 — —
SCHEMBL2012503 0.67 — —
SCHEMBL3284269 0.67 — —
SCHEMBL31251896 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-217139297-U Extraction device is used in production of 3-amino-hydroxyl pyrrolidine-tert-butyl formate 南京道尔顿化学技术有限公司 2022-08-09 — — CN claimed
CN-217139297-U Extraction device is used in production of 3-amino-hydroxyl pyrrolidine-tert-butyl formate 南京道尔顿化学技术有限公司 2022-08-09 — — CN disclosed
CN-217139297-U Extraction device is used in production of 3-amino-hydroxyl pyrrolidine-tert-butyl formate 南京道尔顿化学技术有限公司 2022-08-09 — — CN disclosed
CN-217139297-U Extraction device is used in production of 3-amino-hydroxyl pyrrolidine-tert-butyl formate 南京道尔顿化学技术有限公司 2022-08-09 — — CN disclosed
CN-105579575-A Compositions and methods for treating metabolic disorders VEROSCIENCE LLC 2016-05-11 — — CN disclosed
EP-3008167-A1 COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS VeroScience LLC (US) 2016-04-20 — — EP disclosed
WO-2014201411-A1 COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS VEROSCIENCE LLC (US) 2014-12-18 — — WO disclosed
Send feedback